The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease.
- Resource Type
- Article
- Authors
- Nishiyama, Naoki; Honda, Takayuki; Sema, Manabu; Kawahara, Tatsuo; Jin, Yasuto; Natsume, Ichiro; Chiaki, Tomoshige; Yamashita, Takaaki; Tsukada, Yoshikazu; Taki, Reiko; Miyashita, Yoshihiro; Saito, Kazuhito; Tateishi, Tomoya; Sakashita, Hiroyuki; Miyazaki, Yasunari
- Source
- International Journal of Clinical Oncology. Feb2020, Vol. 25 Issue 2, p282-291. 10p.
- Subject
- *LUNG cancer
*NON-small-cell lung carcinoma
*LUNG diseases
*CANCER patients
*INTERSTITIAL lung diseases
*LOGISTIC regression analysis
- Language
- ISSN
- 1341-9625
Background: Acute exacerbation (AE) of interstitial lung disease (ILD) is a fatal adverse event in the treatment of lung cancer patients with ILD. The value of pre-treatment radiological findings obtained by high-resolution computed tomography for the detection of anticancer treatment-related AE of ILD has not been established. Methods: Two medical record-based retrospective studies were performed. The chemotherapy cohort included 105 lung cancer patients with ILD who received chemotherapy at Tokyo Medical and Dental University between October 2008 and December 2017. The immune checkpoint inhibitor (ICI) cohort included 48 advanced non-small cell lung cancer patients with ILD treated with ICIs at nine institutions between January 2016 and September 2018. Variables were compared between AE-positive and -negative groups. Candidate variables were analyzed by multivariate logistic regression. A P value < 0.05 was considered statistically significant. Results: Anticancer treatment-related AE of ILD occurred in 12 patients (11.4%) in the chemotherapy cohort and seven patients (14.5%) in the ICI cohort. In the multivariate logistic regression analysis, ground-glass attenuation (GGA) score was the only factor significantly associated with the development of AE of ILD in both cohorts (P = 0.037 and 0.01 in the chemotherapy and ICI cohorts, respectively). Conclusion: Evaluation of GGA may help predict anticancer treatment-related AE of ILD. [ABSTRACT FROM AUTHOR]